Mahrukh Imran

ORCID: 0000-0002-2478-0182
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Maternal Mental Health During Pregnancy and Postpartum
  • Meta-analysis and systematic reviews
  • Mental Health Treatment and Access
  • Mental Health Research Topics
  • Health Systems, Economic Evaluations, Quality of Life
  • SARS-CoV-2 and COVID-19 Research
  • Maternal and Perinatal Health Interventions
  • Health disparities and outcomes
  • Child and Adolescent Psychosocial and Emotional Development
  • Cardiac Health and Mental Health
  • Health Policy Implementation Science
  • Ethics in Clinical Research
  • Delphi Technique in Research
  • Pneumonia and Respiratory Infections
  • Machine Learning in Healthcare
  • Vaccine Coverage and Hesitancy
  • Health and Wellbeing Research
  • Health and Well-being Studies
  • Clinical practice guidelines implementation
  • Attachment and Relationship Dynamics
  • scientometrics and bibliometrics research
  • Aging and Gerontology Research
  • Homicide, Infanticide, and Child Abuse

Seqirus (United States)
2025

Jewish General Hospital
2018-2024

McGill University
2020

Sean McGrath Xiaofei Zhao Russell Steele Brett D. Thombs Andrea Benedetti and 93 more Brooke Levis Kira E. Riehm Nazanin Saadat Alexander W. Levis Marleine Azar Danielle B. Rice Kuan‐Pin Su Ankur Krishnan Chen He Wu Yin Parash Mani Bhandari Dipika Neupane Mahrukh Imran Jill Boruff Pim Cuijpers Simon Gilbody John P. A. Ioannidis Lorie A. Kloda Dean McMillan Scott B. Patten Ian Shrier Roy C. Ziegelstein Dickens H. Akena Bruce Arroll Liat Ayalon Hamid Reza Baradaran Murray Baron Anna Beraldi Charles H. Bombardier Peter Butterworth Gregory Carter Marcos Hortes Nisihara Chagas Juliana C.N. Chan Rushina Cholera Neerja Chowdhary Kerrie Clover Yeates Conwell Janneke M. de Man‐van Ginkel Jaime Delgadillo Jesse R. Fann Felix Fischer Benjamin Fischler Daniel Fung Bizu Gelaye Felicity Goodyear‐Smith Catherine G. Greeno Brian J. Hall Patricia A. Harrison Martin Härter Ulrich Hegerl Leanne Hides Stevan E. Hobfoll Marie Hudson Thomas Hyphantis Masatoshi Inagaki Khalida Ismail Nathalie Jetté Mohammad E. Khamseh Kim M. Kiely Yunxin Kwan Femke Lamers Shen‐Ing Liu Manote Lotrakul Sônia Regina Loureiro Bernd Löwe Laura Marsh Anthony McGuire Sherina Mohd Sidik Tiago N. Munhoz Kumiko Muramatsu Flávia de Lima Osório Vikram Patel Brian W. Pence Philippe Persoons Angelo Picardi Katrin Reuter Alasdair G Rooney Iná S. Santos Juwita Shaaban Abbey Sidebottom Adam Simning Lesley Stafford Sharon C. Sung Pei Lin Lynnette Tan Alyna Turner Christina M. van der Feltz‐Cornelis Henk van Weert Paul A. Vöhringer Jennifer White Mary A. Whooley Kirsty Winkley Mitsuhiko Yamada Yuying Zhang

Researchers increasingly use meta-analysis to synthesize the results of several studies in order estimate a common effect. When outcome variable is continuous, standard meta-analytic approaches assume that primary report sample mean and deviation outcome. However, when skewed, authors sometimes summarize data by reporting median one or both (i) minimum maximum values (ii) first third quartiles, but do not deviation. To include these meta-analysis, methods have been developed from reported...

10.1177/0962280219889080 article EN Statistical Methods in Medical Research 2020-01-30

Randomised controlled trials are increasingly conducted as embedded, nested, or using cohorts routinely collected data, including registries, electronic health records, and administrative databases, to assess if participants eligible for the trial facilitate recruitment, deliver an embedded intervention, collect outcome a combination of these purposes. This report presents Consolidated Standards Reporting Trials (CONSORT) extension randomised data (CONSORT-ROUTINE). The was developed look at...

10.1136/bmj.n857 article EN cc-by BMJ 2021-04-29

Real-world evidence (RWE) increasingly informs public health and healthcare decisions worldwide. A large database has been created (“Integrated Dataset”) that integrates primary care electronic medical records with pharmacy claims data on >123 million US patients since 2014. This article describes the components of Integrated Dataset evaluates its representativeness to population potential use in evaluating influenza vaccine effectiveness. Representativeness (2014−2019) was evaluated by...

10.3390/vaccines10050727 article EN cc-by Vaccines 2022-05-06

Abstract Background Selective reporting of results from only well-performing cut-offs leads to biased estimates accuracy in primary studies questionnaire-based screening tools and meta-analyses that synthesize results. Individual participant data meta-analysis (IPDMA) sensitivity specificity at each cut-off via bivariate random-effects models (BREMs) can overcome this problem. However, IPDMA is laborious depends on the ability successfully obtain datasets, BREMs ignore correlation between...

10.1186/s12874-023-02134-w article EN cc-by BMC Medical Research Methodology 2024-02-01

Among young adults, diabetes affects increasing numbers of persons and this is a cause for alarm as public health concern. Paleolithic nutrition depression are some the factors underlying condition. This study, therefore, aims at examining relationship between nutrition, lifestyle, mental well-being, among individuals aged 18 40 in Kenya. In case, research surveyed level junk food intake well levels, awareness diabetes, amount physical training participants had, to illustrate link poor diet,...

10.71146/kjmr193 article EN cc-by 2025-01-11

Background: Egg-based influenza vaccine production can lead to the accumulation of mutations that affect antigenicity. The mammalian cell-based inactivated quadrivalent (IIV4c) may improve effectiveness compared with egg-based vaccines. This study estimated relative (rVE) IIV4c versus (IIV4e) in preventing influenza-related medical encounters (IRME) among children and adolescents during 2019–2020 US season. Methods: retrospective cohort used a dataset linking primary specialty care...

10.1097/inf.0000000000003620 article EN cc-by-nc-nd The Pediatric Infectious Disease Journal 2022-06-04

ABSTRACT Background Adults ≥ 65 years of age have suboptimal influenza vaccination responses compared to younger adults due age‐related immunosenescence. Two vaccines were specifically developed enhance protection: MF59‐adjuvanted trivalent vaccine (aIIV3) and high‐dose egg‐based (HD‐IIV3e). Methods In a retrospective cohort study conducted using US electronic medical records linked claims data during the 2019–2020 season, we relative effectiveness (rVE) aIIV3 with HD‐IIV3e standard‐dose...

10.1111/irv.13288 article EN cc-by Influenza and Other Respiratory Viruses 2024-04-01

Abstract Background Mutations occurring during egg-based influenza vaccine production may affect effectiveness. The mammalian cell-based quadrivalent inactivated (IIV4c) demonstrated improved protection relative to vaccines in prior seasons. This study estimated the effectiveness (rVE) of IIV4c versus standard-dose (IIV4e) preventing influenza-related medical encounters (IRMEs) 2019–2020 US season. Methods retrospective cohort was conducted using a dataset linking electronic records with and...

10.1093/ofid/ofac532 article EN Open Forum Infectious Diseases 2022-10-01

10.1016/j.jclinepi.2021.03.031 article EN Journal of Clinical Epidemiology 2021-04-08

MF59®-adjuvanted trivalent inactivated influenza vaccine (aIIV3) and high-dose (HD-IIV3) elicit an enhanced immune response in older adults compared to standard, quadrivalent vaccines (IIV4). We sought determine the relative effectiveness (rVE) of aIIV3 versus IIV4 HD-IIV3 preventing influenza-related medical encounters this retrospective cohort study involving ≥65 years with ≥1 health condition during 2017–2018 2018–2019 seasons. Data were obtained from primary specialty care electronic...

10.3390/vaccines9080862 article EN cc-by Vaccines 2021-08-05

Higher rates of influenza-related morbidity and mortality occur in individuals with underlying medical conditions. To improve vaccine effectiveness, cell-based technology for influenza manufacturing has been developed. Cell-derived inactivated quadrivalent vaccines (cIIV4) may protection seasons which egg-propagated viruses undergo mutations that affect antigenicity. This study aimed to estimate the relative effectiveness (rVE) cIIV4 versus egg-derived (eIIV4) preventing encounters...

10.1093/ofid/ofab167 article EN cc-by-nc-nd Open Forum Infectious Diseases 2021-04-02

Age-related immunosenescence may impair the immune response to vaccination in older adults. Adjuvanted influenza vaccines are designed overcome senescence This study estimated relative vaccine effectiveness (rVE) of MF59-adjuvanted trivalent inactivated (aIIV3) vs egg-derived quadrivalent (IIV4e) and high-dose (HD-IIV3) preventing influenza-related medical encounters 2019-2020 US season.This retrospective cohort used electronic records linked pharmacy claims data. The population included...

10.1093/ofid/ofac167 article EN cc-by-nc-nd Open Forum Infectious Diseases 2022-04-02
Coming Soon ...